|
Volumn 37, Issue 7, 2002, Pages 580-581
|
Are glucocorticoids really useful for the treatment of acute pancreatitis?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CHEMOKINE;
CYTOKINE;
GLUCOCORTICOID;
IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;
INTERLEUKIN 1BETA;
INTERLEUKIN 6;
METHYLPREDNISOLONE;
SYNAPTOTAGMIN;
TRANSCRIPTION FACTOR;
TRYPSINOGEN;
TRYPSINOGEN ACTIVATION PEPTIDE;
ANTIINFLAMMATORY AGENT;
ACINAR CELL;
ACUTE PANCREATITIS;
ANIMAL CELL;
ASCITES;
CONTROLLED STUDY;
DOSE RESPONSE;
DRUG EFFICACY;
DRUG PULSE THERAPY;
EDITORIAL;
HEMOCONCENTRATION;
HUMAN;
HUMAN CELL;
INFLAMMATORY CELL;
KIDNEY BLOOD FLOW;
NONHUMAN;
PANCREAS DUCT;
PATHOGENESIS;
PRIORITY JOURNAL;
PROPHYLAXIS;
PROTEIN EXPRESSION;
RAT;
ACUTE DISEASE;
ANIMAL;
METABOLISM;
NOTE;
PANCREATITIS;
ACUTE DISEASE;
ANIMAL;
ANTI-INFLAMMATORY AGENTS, STEROIDAL;
GLUCOCORTICOIDS, SYNTHETIC;
HUMAN;
METHYLPREDNISOLONE;
NF-KAPPA B;
PANCREATITIS;
RATS;
ANIMALS;
ANTI-INFLAMMATORY AGENTS;
GLUCOCORTICOIDS;
HUMANS;
|
EID: 0035992602
PISSN: 09441174
EISSN: None
Source Type: Journal
DOI: 10.1007/s005350200092 Document Type: Editorial |
Times cited : (5)
|
References (18)
|